Significance of cytogenetic-risk categories and refined international prognostic scoring system for overall survival in primary myelofibrosis: A single-center experience
Open Access
- 1 January 2020
- journal article
- research article
- Published by National Library of Serbia in Vojnosanitetski Pregled
- Vol. 77 (5) , 516-524
Abstract
Background/Aim. Primary myelofibrosis (PMF) is a chronic, malignant hematological disease characterized by a leucoerythroblastic blood picture, anisopoikilocytosis teardrop- shaped erythrocytes, different degrees of bone marrow fibrosis and hepatosplenomegaly due to extramedullary hematopoiesis. Among genetic specificities of the disease, those that stand out are chromosomal aberrations in pathological, myeloid blood cells. The aim of this study was to examine the prognostic significance of clinical, hematologic and cytogenetic parameters in PMF. Methods. A retrospective study included 144 patients with PMF. Karyotypes were analyzed using conventional cytogenetic methods. Results. The chromosome examinations were successful in 126 (88%) patients and failed in the remainder ones (12%). Karyotype was abnormal in 36/126 (29%) subjects at presentation. The most frequent changes included +9, 13q- and 20q- (28%). Other abnormalities were: aberrations of chromosome 18 and 16, deletions (9q-, 12p-, 7q-, 5q-, 6q-, 8q-), trisomies (+1q, +8, +10, +21), monosomies (-7, -11), 3q inversion and loss of Y chromosome. We detected four novel balanced translocations in PMF: t(17;22)(q11;q13), t(15;17)(q22;q25), t(9;12)(q22;q24) and t(2;4)(q21;p16), one constitutional translocation-rob(13;14)(q10;q10) and some new karyotype anomalies ? deletion of both homologues, hyperdiploidy and the coexistence of unrelated pathological clones. Conclusion. Chromosomal aberrations had a significant influence on overall survival of patients with PMF according to the refined cytogenetic-risk of the International Prognostic Scoring System (Refined CIPSS) (p = 0.004). Our patients matched the pattern of chromosome aberrations usually observed in PMF but some newly registered, balanced translocations and other rare karyotype anomalies were recorded as well.Keywords
Funding Information
- Ministry of Education, Science and Technological Development of the Republic of Serbia (III 41004)
This publication has 19 references indexed in Scilit:
- Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patientsLeukemia, 2010
- Pattern of trisomy 1q in hematological malignancies: a single institution experienceCancer Genetics and Cytogenetics, 2008
- Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisLeukemia Research, 2007
- Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithmsLeukemia, 2007
- Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatmentLeukemia, 2007
- Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patientsCancer Genetics and Cytogenetics, 2007
- Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasiaCancer, 2005
- Constitutional chromosome aberrations as pathogenetic events in hematologic malignanciesCancer Genetics and Cytogenetics, 2004
- Rapid method for obtaining high-quality chromosome banding in the study of hematopoietic neoplasiaCancer Genetics and Cytogenetics, 1994
- Involvement of bands 9q21–q22 in five cases of acute nonlymphocytic leukemiaCancer Genetics and Cytogenetics, 1989